SCOPE: Summit for Clinical Ops Executives
Now in its 15th year of fostering joint efforts to advance our medical knowledge inclusive of all stakeholders, SCOPE Summit 2024 will offer over four stimulating days of in-depth discussions and networking through sessions, plenary keynotes, the exhibit hall and special awards. The programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management, operations, and investment. SCOPE welcomes more than 3,500 attendees, 850 different organizations, from 27 countries, in clinical operations, clinical trials, innovation, and research.
Make sure you take some time to visit the Clario Booth #807 to learn what’s new!
Session information:
Title: Unlocking AI’s Potential in Clinical Trials: Navigating Bias, Misconceptions, and Future Opportunities
Date: Monday, February 12th, 2023
Time: 4:25 p.m. ET
Location: Clinical Data Strategy and Analytics Track
Abstract:
This session will explore the transformative role of AI in clinical trials: where we are today, common misconceptions in leveraging AI, proactively tackling the potential for bias, and navigating the current regulatory landscape. Participants will gain an understanding of the responsible application of AI-enabled algorithms in clinical trial endpoint collection and data analysis.
Speaker
Todd Rudo, M.D.
Chief Medical Officer at Clario
As Clario’s Chief Medical Officer, Dr. Todd Rudo provides medical and scientific leadership across the organization. Passionate about leveraging Clario’s scientific resources to support customer success, Dr. Rudo has focused efforts on developing expertise across a range of therapeutic areas. His team provides expert consulting to clients on scientific and regulatory strategy, and ensures Clario’s product portfolio is scientifically robust, generating high quality clinical trial endpoint data. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials, while also maintaining focus on patient and site burden. With nearly 20 years of clinical cardiology and pharmaceutical research experience, Dr. Rudo has focused predominantly on drug safety, working across a wide range of therapeutic areas.
Meet with us at SCOPE Summit 2024
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.